Expression of nectin-4 in papillary renal cell carcinoma

Stefanie Zschäbitz1, Marie Mikuteit2,3, Christine Stöhr4

  • 1Dept. of Medical Oncology, National Center of Tumor Diseases, University Hospital Heidelberg, 69120, Heidelberg, Germany.

Discover Oncology
|September 22, 2022
PubMed
Abstract

Insights

Nectin-4 is frequently expressed in papillary renal cell carcinoma (pRCC), particularly type 1. While not a general prognostic marker, its abundance suggests Nectin-4 is a promising therapeutic target for pRCC.

Area of Science:

  • Oncology
  • Uro-oncology
  • Molecular Pathology

Background:

  • Nectin-4 promotes tumor growth and vascularization, making it a key target in cancer therapy.
  • Current treatments for renal cell carcinoma (RCC) include tyrosine kinase inhibitors and checkpoint inhibitors.
  • Enfortumab vedotin-ejf (EV) is an antibody-drug conjugate targeting Nectin-4.

Purpose of the Study:

  • To investigate the expression levels of Nectin-4 in a large cohort of papillary renal cell carcinoma (pRCC) specimens.
  • To assess the potential of Nectin-4 as a prognostic marker and therapeutic target in pRCC.

Main Methods:

  • Analysis of tissue samples from 190 patients with pRCC type 1 and 107 patients with pRCC type 2.
  • Immunohistochemistry (IHC) was used to determine Nectin-4 expression.
  • Clinical data including age, gender, grading, TNM stage, and survival rates were analyzed.

Main Results:

  • Nectin-4 was moderately or strongly positive in 48.4% of type 1 pRCC and 36.4% of type 2 pRCC.
  • No significant association was found between Nectin-4 expression and clinicopathological factors (age, gender, grade, stage).
  • Five-year overall survival was higher in Nectin-4 positive type 1 pRCC compared to negative cases (81.3% vs. 67.8%, p=0.042).

Conclusions:

  • Nectin-4 expression is common in pRCC, especially type 1, but does not serve as a general prognostic marker.
  • High Nectin-4 abundance on pRCC specimens identifies it as a potential therapeutic target, for example, with Enfortumab vedotin-ejf.
  • Further clinical trials are necessary to confirm the role of Nectin-4 in pRCC treatment strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.1K
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K